TY - JOUR
T1 - Middle east consensus statement on the prevention, diagnosis, and management of cow's milk protein allergy
AU - Vandenplas, Yvan
AU - Abuabat, Ahmed
AU - Al-Hammadi, Suleiman
AU - Aly, Gamal Samy
AU - Miqdady, Mohamad S.
AU - Shaaban, Sanaa Youssef
AU - Torbey, Paul Henri
N1 - Publisher Copyright:
© 2014 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition.
PY - 2014
Y1 - 2014
N2 - Presented are guidelines for the prevention, diagnosis, and treatment of cow's milk protein allergy (CMPA) which is the most common food allergy in infants. It manifests through a variety of symptoms that place a burden on both the infant and their caregivers. The guidelines were formulated by evaluation of existing evidence-based guidelines, literature evidence and expert clinical experience. The guidelines set out practical recommendations and include algorithms for the prevention and treatment of CMPA. For infants at risk of allergy, appropriate prevention diets are suggested. Breastfeeding is the best method for prevention; however, a partially hydrolyzed formula should be used in infants unable to be breastfed. In infants with suspected CMPA, guidelines are presented for the appropriate diagnostic workup and subsequent appropriate elimination diet for treatment. Exclusive breastfeeding and maternal dietary allergen avoidance are the best treatment. In infants not exclusively breastfed, an extensively hydrolyzed formula should be used with amino acid formula recommended if the symptoms are life-threatening or do not resolve after extensively hydrolyzed formula. Adherence to these guidelines should assist healthcare practitioners in optimizing their approach to the management of CMPA and decrease the burden on infants and their caregivers.
AB - Presented are guidelines for the prevention, diagnosis, and treatment of cow's milk protein allergy (CMPA) which is the most common food allergy in infants. It manifests through a variety of symptoms that place a burden on both the infant and their caregivers. The guidelines were formulated by evaluation of existing evidence-based guidelines, literature evidence and expert clinical experience. The guidelines set out practical recommendations and include algorithms for the prevention and treatment of CMPA. For infants at risk of allergy, appropriate prevention diets are suggested. Breastfeeding is the best method for prevention; however, a partially hydrolyzed formula should be used in infants unable to be breastfed. In infants with suspected CMPA, guidelines are presented for the appropriate diagnostic workup and subsequent appropriate elimination diet for treatment. Exclusive breastfeeding and maternal dietary allergen avoidance are the best treatment. In infants not exclusively breastfed, an extensively hydrolyzed formula should be used with amino acid formula recommended if the symptoms are life-threatening or do not resolve after extensively hydrolyzed formula. Adherence to these guidelines should assist healthcare practitioners in optimizing their approach to the management of CMPA and decrease the burden on infants and their caregivers.
KW - Allergy and immunology
KW - Breast feeding
KW - Hypersensitivity
KW - Infant formula
KW - Milk hypersensitivity
UR - http://www.scopus.com/inward/record.url?scp=84951975023&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84951975023&partnerID=8YFLogxK
U2 - 10.5223/pghn.2014.17.2.61
DO - 10.5223/pghn.2014.17.2.61
M3 - Review article
AN - SCOPUS:84951975023
SN - 2234-8646
VL - 17
SP - 61
EP - 73
JO - Pediatric Gastroenterology, Hepatology and Nutrition
JF - Pediatric Gastroenterology, Hepatology and Nutrition
IS - 2
ER -